Stryker Sales Aided By Expanding Domestic Orthopedic Implant Business
This article was originally published in The Gray Sheet
Executive Summary
Stryker is experiencing a "resurgence" in its U.S. orthopedics division, aided by double-digit growth of reconstructive implant sales
You may also be interested in...
S&N’s Potential Biomet Acquisition Would Create Top-Tier Ortho Player
Smith & Nephew is weighing a potential acquisition of Biomet that would create a top-tier reconstructive orthopedic implant player and tighten competition with rivals Zimmer, Stryker and Johnson & Johnson/DePuy
S&N’s Potential Biomet Acquisition Would Create Top-Tier Ortho Player
Smith & Nephew is weighing a potential acquisition of Biomet that would create a top-tier reconstructive orthopedic implant player and tighten competition with rivals Zimmer, Stryker and Johnson & Johnson/DePuy
Stryker expands hip offerings
September global launch of Stryker's LFIT anatomic femoral heads with X3 polyethylene liners follows 510(k) clearance, announced Aug. 25. Designed to maximize hip stability, the alternative to metal-on-metal bearings uses low friction ion treatment technology and is "anatomically sized for more natural hip performance," Stryker claims. "Up until now, metal-on-metal options in larger sizes only met the needs of a subset of the total hip population"...